Cybin Reports Positive Topline Data From Phase 2 Study Of CYB003 in Major Depressive Disorder Nov 30, 2023
Cybin Phase 2 Major Depressive Disorder Study Demonstrates Rapid and Remarkable Outcomes Oct 31, 2023
